Sodium Hydroxide → HCID 58235201, compound
Reaction equation
C[O:2][C:3](=[O:30])[C:4]1[CH:9]=[CH:8][C:7]([C:10]2[CH:15]=[CH:14][N:13]=[C:12]([CH2:16][CH3:17])[C:11]=2[C:18]#[C:19][C:20]2[C:21]([CH2:27][CH3:28])=[N:22][C:23]([NH2:26])=[CH:24][CH:25]=2)=[CH:6][C:5]=1[F:29].[OH-].[Na+]>C1COCC1.O>[NH2:26][C:23]1[N:22]=[C:21]([CH2:27][CH3:28])[C:20]([C:19]#[C:18][C:11]2[C:12]([CH2:16][CH3:17])=[N:13][CH:14]=[CH:15][C:10]=2[C:7]2[CH:8]=[CH:9][C:4]([C:3]([OH:30])=[O:2])=[C:5]([F:29])[CH:6]=2)=[CH:25][CH:24]=1Participants
5
Reactant 2
Product 1
Reagents, catalysts & solvents 2
Procedure
The title compound is synthesized according to general procedure GP4 starting from 944 mg (2.34 mmol) 4-[3-(6-Amino-2-ethyl-pyridin-3-ylethynyl)-2-ethyl-pyridin-4-yl]-2-fluoro-benzoic acid methyl ester (A-43) using 3.5 mL (3.5 mmoL) 1N NaOH in 25 mL THF. The reaction mixture is diluted with water and the product extracted with DCM. The organic phase is separated and the solvent removed under reduced pressure. The crude product is used without further purification. Yield: 945 mg (>100%).
Workup
- extractionthe product extracted with DCM
- customThe organic phase is separated
- customthe solvent removed under reduced pressure
- customThe crude product is used without further purification
Sources & evidence
- ORD record
- ord-cf0e3c1edde2468d8c34f9629d9592f0
- Source dataset
- uspto-grants-2015_07
- Patent number
- US09090564B2
Reaction notes
Loading…